Bard patent upheld in $185m Gore row:
This article was originally published in Clinica
Executive Summary
C R Bard has been awarded $185m in past damages after a US court ruled that W L Gore & Associates had infringed one of the former's patents. The district court of Arizona upheld the validity of Bard's patent '135 and found that certain components of Gore's ePTFE vascular grafts and stent-grafts range had wilfully infringed the patent. The same court is also assessing Gore's claims that the patent is unenforceable due to inequitable conduct. Bard said that it expects Gore to file post-trial motions to the Court of Appeals, after the jury's decision.